Urothelial Carcinoma Urethra
2 clinical trials · Condition
◉ Watch Urothelial Carcinoma Urethra
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma (NCT03606174) | Mirati Therapeutics Inc. | 2018-09-11 |
Track Urothelial Carcinoma Urethra automatically
Every clearance here is in the API, with alerts when new ones post.